Xtant Medical Holdings (XTNT) Net Shares Issued and Repurchased (2018 - 2025)

Xtant Medical Holdings (XTNT) has reported Net Shares Issued and Repurchased for 8 consecutive years, with $164432.0 the latest figure, recorded in Q1 2025.

• On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $164432.0 in Q1 2025; TTM through Mar 2025 was $164432.0, a N/A change from a year earlier, with the FY2024 full-year figure at $953629.0, down 40.47% from the prior year.
• Net Shares Issued and Repurchased was $164432.0 for Q1 2025 at Xtant Medical Holdings, down from $953629.0 in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $1.6 million in Q4 2023 and troughed at $125.0 in Q1 2021.
• A 5-year average of $592673.5 and a median of $452053.0 in 2022 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased plunged 99.84% in 2021 and jumped 241486.4% in 2022, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.0 million in 2021, then plunged by 40.51% to $602123.0 in 2022, then soared by 166.06% to $1.6 million in 2023, then tumbled by 40.47% to $953629.0 in 2024, then slumped by 82.76% to $164432.0 in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $164432.0 (Q1 2025), $953629.0 (Q4 2024), and $1.6 million (Q4 2023), per Business Quant data.